The Patent Finder

Terms ending in 2026

Pharmacyclics, Inc.

Every in-force patent on Pharmacyclics, Inc.'s record whose computed term ends in 2026, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 7,514,444Inhibitors of Bruton's Tyrosine Kinase
In force
 · Medium confidence
Pharmacyclics LLCIn forceMedium confidence
US 7,960,396Inhibitors of Bruton's Tyrosine Kinase
In force
 · Medium confidence
Pharmacyclics LLCIn forceMedium confidence
US 8,158,786Inhibitors of Bruton's Tyrosine Kinase
In force
 · Medium confidence
Pharmacyclics LLCIn forceMedium confidence
US 8,232,280Inhibitors of Bruton's Tyrosine Kinase
In force
 · Low confidence
Pharmacyclics LLCIn forceLow confidence
US 8,236,812Inhibitors of Bruton's Tyrosine Kinase
In force
 · High confidence
Pharmacyclics LLCIn forceHigh confidence
US 8,399,470Inhibitors of Bruton's Tyrosine Kinase
In force
 · Low confidence
Pharmacyclics LLCIn forceLow confidence
US 8,476,284Inhibitors of Bruton's Tyrosine Kinase
In force
 · Low confidence
Pharmacyclics LLCIn forceLow confidence
US 8,497,277Inhibitors of Bruton's Tyrosine Kinase
In force
 · Low confidence
Pharmacyclics LLCIn forceLow confidence
US 8,501,751Inhibitors of Bruton's Tyrosine Kinase
In force
 · Medium confidence
Pharmacyclics LLCIn forceMedium confidence
US 8,552,010Inhibitors of Bruton's Tyrosine Kinase
In force
 · High confidence
Pharmacyclics LLCIn forceHigh confidence
24 more term ends in 2026 · Pro
10 of 34 patents shown. Soonest term end first, then patent number.
Pro members see all 34, all of them expiring within the 18 months from Nov 20, 2026.
Upgrade to Pro
Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited